Table 2.

The relationship between CHD9 expression and the ccRCC patients’ clinical index

				Gender	Age	Pathological grading	Tumor size	T	N	M	Clinical staging
Spearman’s rho	Cytoplasm CHD9 expression	Tumor	Correlation Coefficient	-0.084	0.027	0.330**	0.057	0.241*	0.029	0.026	0.250*
			Sig. (2-tailed)	0.437	0.805	0.002	0.596	0.024	0.792	0.808	0.020
		Adjacent	Correlation Coefficient	0.024	-0.138	-0.231*	-0.188	0.017	-0.028	-0.119	0.008
			Sig. (2-tailed)	0.826	0.207	0.031	0.081	0.879	0.802	0.274	0.945
	Nucleus CHD9 expression	Tumor	Correlation Coefficient	-0.004	0.027	-0.108	-0.056	-0.046	0.111	-0.092	-.012
			Sig. (2-tailed)	0.969	0.804	0.318	0.606	00.672	0.307	0.395	0.913
		Adjacent	Correlation Coefficient	-0.045	-0.069	-0.005	0.021	-0.081	-0.039	-0.038	-0.091
			Sig. (2-tailed)	0.682	0.530	0.961	0.850	0.455	0.723	0.728	0.412

^**Correlation is significant at the 0.01 level (2-tailed).

^*Correlation is significant at the 0.05 level (2-tailed).